Health-related quality of life with first- vs second-line CDK4/6 inhibitor use in advanced breast cancer: results from the SONIA trial

Authors

Institutions

Publication Details

Journal
JNCI Journal of the National Cancer Institute
Published
2025-11-20
DOI
https://doi.org/10.1093/jnci/djaf334
Citations
1
Primary Topic
Advanced Breast Cancer Therapies
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Health-related quality of life with first- vs second-line CDK4/6 inhibitor use in advanced breast cancer: results from the SONIA trial

Cathrien S. Tromp-van Driel, Christa van Schaik - van de Mheen, Hedwig M. Blommestein, Aart Beeker et al.
1 citations
JNCI Journal of the National Cancer Institute
Advanced Breast Cancer Therapies
1.52
article

Health-related quality of life with first- vs second-line CDK4/6 inhibitor use in advanced breast cancer: results from the SONIA trial

Cathrien S. Tromp-van Driel, Christa van Schaik - van de Mheen, Hedwig M. Blommestein, Aart Beeker, Suzan Vrijaldenhoven, Vincent van der Noort, Gabe S. Sonke, Joan B. Heijns, A. Elise van Leeuwen‐Stok, Quirine C. van Rossum‐Schornagel, Agnes Jager, Karin Beelen, Lisanne C. Hamming, E. van den Pol, Cristina Guerrero Páez, Annemiek van Ommen‐Nijhof, Noor Wortelboer, Inge R. Konings, Paul C. de Jong, Jolien Tol, Aafke H. Honkoop, Seamus Kent
article en
1 citations

Abstract

No abstract available for this paper.
JNCI Journal of the National Cancer InstituteVol. 118(3)
Breast Cancer Research Foundation (US), Dutch Cancer Society (NL), Gelre Hospitals (NL), Medisch Centrum Leeuwarden (NL), The Netherlands Cancer Institute (NL), Spaarne Ziekenhuis (NL), Northwest Hospital (US), St. Antonius Ziekenhuis (NL), Amphia Ziekenhuis (NL), Borstkankervereniging Nederland (NL), Oncode Institute (NL), Netherlands Comprehensive Cancer Organisation (NL), Isala (NL), Erasmus MC Cancer Institute (NL), Franciscus Vlietland (NL), Amsterdam University Medical Centers (NL), Rijnstate Hospital (NL), Meander Medisch Centrum (NL), Jeroen Bosch Ziekenhuis (NL), University of Amsterdam (NL), Erasmus University Rotterdam (NL)
Openalex Percentile: Top 13%
Advanced Breast Cancer Therapies
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.